Harland Medical Systems to begin operations in Costa Rica

  • The company’s new site will be located at The Green Park Free Zone in Alajuela. 
  • Operations are expected to begin in July. 

San José, 22 January 2025 – Harland Medical Systems, a U.S.-based company focused on developing and producing specialized coatings for the medical device industry, is set to begin operations in Costa Rica this year. 

The Minnesota-headquartered company will establish a new 1,000 m² facility at The Green Park Free Zone, Alajuela, becoming Costa Rica’s first vendor of hydrophilic coatings, a strategic service for the MedTech sector. 

“Harland is thrilled to expand our operations to Costa Rica, enabling us to better support our customers at every stage of their coating journey. We are eager to embrace the rich culture, dynamic workforce, and fresh perspectives that Costa Rica brings. This investment marks an exciting step toward serving even more customers worldwide with the same dedication and even greater capacity in the near future”, commented Jon Anderson, Founder & CEO of Harland Medical. 

Operations are scheduled to begin in July, with plans for future expansion in the coming years. This initial phase will offer dedicated high throughput coating services and local maintenance and support for medical equipment, complementing Harland Medical’s recent investments in Ireland and Israel. 

“We welcome Harland Medical System and wish that its journey in Costa Rica is filled with success and opportunities for both its operations and many Costa Ricans. This is an example of the companies that trust our country, not only because of our capabilities in the medical device industry but also because they come to interact within a robust ecosystem of more than 90 companies, ranging from service providers in the value chain to high-level manufacturing,” said the Minister of Foreign Trade, Manuel Tovar.  

“Harland Medical Systems’ investment in Costa Rica represents a significant boost to the medical device sector, which leads the country’s exports, accounting for 44% of the total. This achievement highlights Costa Rica’s robust value proposition, supported by extensive industry experience and high-value incentives. These factors position Costa Rica as a strategic partner for med-tech companies seeking a competitive environment to enhance their operations,” said Laura López, General Manager of the Trade and Investment Promotion of Costa Rica (PROCOMER). 

 Harland Medical Systems’ Costa Rican facility will focus on high-volume production, catering to key sectors of the medical industry, including neurology, cardiology, ophthalmology, urology, orthopedics, and more. 

“Our country combines essential factors for technological innovation, such as talent, infrastructure, and sustainability. These elements have positioned Costa Rica as a benchmark for foreign investment and exports in the medical industry, which has become our leading export sector,” López concluded. 

Explore the latest news and updates from the leading companies and discover the investment opportunities in the costarican market.